<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>05</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Serum ox-LDL Level is Reduced with the Extent of Stenosis in Coronary Arteries</title>
    <FirstPage>314</FirstPage>
    <LastPage>319</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Najafi</LastName>
        <affiliation locale="en_US">Department of Biochemistry, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behnam</FirstName>
        <LastName>Alipoor</LastName>
        <affiliation locale="en_US">Department of Biochemistry, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Oxidized LDL (ox-LDL) lipoproteins are proposed as important modified particles triggering pro-inflammatory events through receptor-mediated pathways. We evaluated the circulating ox-LDL level on the concept that the chronic immune events may affect ox-LDL clearance as the vessel stenosis develops in coronary arteries. One hundred sixty five subjects underwent coronary angiography and then, subdivided into four subgroups controls (n=85); SVD, 2VD and 3VD (n=80). The serum ox-LDL level and other biochemical parameters were measured using ELISA method and routine laboratory techniques, respectively. The serum ox-LDL level in the control group (4.81&#xB1;1.41 mU/mg) was significantly higher than patients (4.28&#xB1;1.73 mU/mg, P&lt;0.05). The ox-LDL/LDL ratio was conversely reduced with the extent of stenosis as compared with the controls (P&lt;0.05). Furthermore, no difference was observed in the ox-LDL/LDL ratio between the 2VD and 3VD patients. We suggested the atherosclerosis process increases the total clearing capacities of the circulating ox-LDL particles.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4440</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4440/4588</pdf_url>
  </Article>
</Articles>
